arrow
T

Teresa Macarulla

hospital clinic barcelona
H指数:63
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial

静脉注射表达透明质酸酶的溶瘤腺病毒联合化疗治疗转移性胰腺癌:一项随机IIb期试验

2026-09-300
PRE
EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer

EORTC-1607-GITCG/ABC-09:西吉姆联合帕博利珠单抗治疗晚期或转移性胆道癌的开放标签、单臂II期首线研究

2026-08-010
PRE
Response to Letter to the Editor: 'NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial'

对编辑来信的回应:'NALIRIFOX与nab-紫杉醇和吉西他滨在治疗初治转移性胰腺癌老年患者中的比较:关键性NAPOLI 3试验的亚组分析'

2026-07-010
OAAI
NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial

NALIRIFOX与nab-紫杉醇和吉西他滨在治疗初治转移性胰腺癌老年患者中的比较:NAPOLI 3关键试验的亚组分析

2026-02-120
OAAI
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors

基因组可操作性及匹配的靶向疗法在为期十年的机构实体瘤精准医学项目中的应用

2025-11-060
OAAI
Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapy

可切除胃癌的治疗策略演变:弥合亚西方差异,迈向个体化与整合治疗

2025-10-240
OAAI
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study

伊沃西登ib治疗IDH1突变型肝内胆管癌:一项多中心真实世界研究的见解

2025-08-260
OAAI
Young-Onset Biliary Tract Cancers: Characteristics, Treatment Patterns, and Patient Outcomes

早发型胆道系统癌症:特征、治疗模式及患者预后

2025-08-110
OAAI
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer

候选替代终点与晚期胆道癌总生存率的关系

2025-06-030
PRE
Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain
2025-01-080
OAAI
Exploratory biomarker evaluation of the randomized Phase 2 cohort of CM24 in combination with nivolumab and chemotherapy in advanced/metastatic pancreatic cancer
2024-09-150
PRE
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
2024-08-081
OAAI
SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma

SRC抑制可在异柠檬酸脱氢酶突变型胆管癌中形成生长抑制MAGI1-PP2A复合物

2024-05-152
OA
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort

早发患者胆道癌的管理: ACABI GERCOR PRONOBIL队列的巢式多中心回顾性研究

2024-04-081
OAAI